Morgan Stanley »

Xtl Biopharmaceuticals shares owned by Morgan Stanley

Quarter-by-quarter ownership of Xtl Biopharmaceuticals (XTLB) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Xtl Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xtl Biopharmaceuticals held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xtl Biopharmaceuticals by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $24 10 2.40

More positions owned by Morgan Stanley

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)

View all positions for Morgan Stanley

Top funds holding Xtl Biopharmaceuticals

Noked Israel
SmartHarvest Portfolios
Rhumbline Advisers
GAMMA Investing
Morgan Stanley

View all funds holding Xtl Biopharmaceuticals